TheraRadar
Data updated: Mar 29, 2026

PROPOXYPHENE COMPOUND 65

ASPIRIN
Approved 1970-12-22
Jump to: Indications Approvals Trials Competitors Safety Patents
4
Indications
--
Phase 3 Trials
55
Years on Market

Details

Status
Discontinued
First Approved
1970-12-22
Routes
ORAL
Dosage Forms
CAPSULE

Companies

Teva Novartis IVAX SUB TEVA PHARMS
Active Ingredient: ASPIRIN , CAFFEINE , PROPOXYPHENE HYDROCHLORIDE

PROPOXYPHENE COMPOUND 65 Approval History

Loading approval history...

What PROPOXYPHENE COMPOUND 65 Treats

4 FDA approvals

Originally approved for its first indication in 1970 . Covers 4 distinct patient populations.

  • Other (4)
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...
⭐

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

ClinicalTrials.gov ↗ Pro

Full development history with FDA approval milestones

|
Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

PROPOXYPHENE COMPOUND 65 FDA Label Details

Pro

Want competitive intelligence?

See who's developing similar drugs and track their progress

View Pipeline Dashboard

Data Sources

FDA Approval: ANDA089025 → Trials: ClinicalTrials.gov →

Data sourced from official FDA and NIH databases. Click links to verify on original sources.